SSY Gets Production, Registration Go-Ahead for Extracellular Fluid Supplement Drug

MT Newswires Live
2025/01/03

SSY Group (HKG:2005) obtained approval to produce and register its sodium acetate Ringer's and glucose injection from China's National Medical Products Administration after it passed the latter's consistency evaluation, a Thursday Hong Kong bourse filing said.

Sodium acetate Ringer's and glucose injection is mainly used in the supplement of extracellular fluid and the correction of metabolic acidosis when circulating blood volume and interstitial fluid are reduced, as well as in supplying energy.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10